Platelet activation in type 2 diabetes mellitus
- 1 August 2004
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 2 (8), 1282-1291
- https://doi.org/10.1111/j.1538-7836.2004.00836.x
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- The F 2 -Isoprostane 8-Epiprostaglandin F 2α Increases Platelet Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NOArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Effects of picotamide, an antiplatelet agent, on cardiovascular events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP studyBritish Journal of Clinical Pharmacology, 1996
- Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With MicroalbuminuriaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density LipoproteinBiochemical and Biophysical Research Communications, 1994
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusThe New England Journal of Medicine, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- The platelet insulin receptor: Detection, partial characterization, and search for a functionBiochemical and Biophysical Research Communications, 1988
- Platelet insulin receptor determination in non-insulin dependent diabetes mellitusCellular and Molecular Life Sciences, 1985